DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $214,000 | -13.7% | 6,266 | -7.4% | 0.00% | -100.0% |
| Q2 2021 | $248,000 | -51.1% | 6,764 | -40.2% | 0.00% | 0.0% |
| Q1 2021 | $507,000 | -46.2% | 11,312 | -31.5% | 0.00% | -50.0% |
| Q4 2020 | $942,000 | -29.6% | 16,509 | -36.7% | 0.00% | -50.0% |
| Q3 2020 | $1,338,000 | -10.9% | 26,076 | +3.8% | 0.00% | -20.0% |
| Q2 2020 | $1,501,000 | +24.3% | 25,128 | -19.0% | 0.01% | +25.0% |
| Q1 2020 | $1,208,000 | -12.8% | 31,037 | +39.4% | 0.00% | 0.0% |
| Q4 2019 | $1,386,000 | +68.2% | 22,263 | +6.3% | 0.00% | +33.3% |
| Q2 2018 | $824,000 | – | 20,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
| Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
| BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
| Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
| Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
| ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
| Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
| AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
| Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |